Cleared Traditional

Vista CMS (K250349) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K250349 · Shanghai Draeger Medical Instrument Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2026
Decision
441d
Days
Class 2
Risk

K250349 is an FDA 510(k) clearance for the Vista CMS. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Shanghai Draeger Medical Instrument Co., Ltd. (Shanghai, CN). The FDA issued a Cleared decision on April 24, 2026 after a review of 441 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Shanghai Draeger Medical Instrument Co., Ltd. devices

Submission Details

510(k) Number K250349 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 07, 2025
Decision Date April 24, 2026
Days to Decision 441 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
316d slower than avg
Panel avg: 125d · This submission: 441d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 424
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K250349.
Radius VSM and Accessories
K254209 · Masimo Corporation · Jun 2026
M12 Telemetry System
K252840 · Global Instrumentation, LLC · May 2026
ePM Series Patient Monitor (ePM 10/ePM 10A/ePM 10C/Guardian plus/ ePM 12/ePM 12A/ePM 12C / ePM 15/ePM 15A/ePM 15C /ePM 10M/ ePM 10MA/ ePM 10MC/ePM 12M/ ePM 12MA/ ePM 12MC/ePM 15M/ ePM 15MA/ ePM 15MC)
K260098 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · May 2026
uMEC 60/ uMEC 70/ uMEC 80/uMEC 100/uMEC 120/uMEC 150 Patient Monitors
K253170 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Apr 2026
Vista 300/Vista 300 S
K252250 · Shanghai Draeger Medical Instrument Co., Ltd. · Apr 2026
IntelliVue Multi-Measurement Module X3 (867030)
K252726 · Philips Medizin Systeme Boeblingen GmbH · Feb 2026